Literature DB >> 26033335

Anti-D alloimmunisation in pregnant women with DEL phenotype in China.

M Wang1,2, B L Wang2, W Xu3, D D Fan4, M L Peng4, J Pan1, P Yao2, G M Jiang1, X J Wan1.   

Abstract

OBJECTIVES: To analyse anti-D alloimmunisation in pregnant women with D-elute (DEL) phenotype in China, for developing a predictive model to evaluate whether a person with the DEL phenotype can receive RhD-positive blood.
BACKGROUND: Alloanti-D acquired by pregnancy or transfusion is one of the major causes of both haemolytic disease among newborns and haemolytic transfusion reactions. To date, there is little data available about the antigenic properties and immunogenicity of extremely weak D variants known as DEL.
METHODS: RHD genotyping and D epitope mapping were performed using gene sequencing and comprehensive immunohaematological methods, respectively. DEL pregnant women carrying an RhD-positive fetus were tested for the presence of alloanti-D.
RESULTS: A total of 130 of 142 (91·5%) pregnant women with a DEL phenotype were confirmed to carry the RHD (K409K) allele. Among 12 DEL women who appeared to have RHD-CE-D hybrid alleles, there were 1 RHD-CE (4-7)-D, 7 RHD-CE(4-9)-D, and 4 RHD-CE (2-5)-D alleles. Alloanti-D antibodies were detected in 6 of 142 DEL women, and all the six women had the partial DEL phenotype.
CONCLUSION: The data indicate that partial DEL women appear at risk of alloimmunization to the D antigen. RhD immune globulin prophylaxis is necessary for partial DEL women. Partial DEL patients should receive only RhD-negative RBCs, whereas DEL patients with complete expression of antigen can safely receive RhD-positive RBCs.
© 2015 British Blood Transfusion Society.

Entities:  

Keywords:  HDN; RBC transfusion; alloimmunization; donors; partial DEL

Mesh:

Substances:

Year:  2015        PMID: 26033335     DOI: 10.1111/tme.12211

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  6 in total

1.  [Genotyping of RhD-negative blood samples diagnosed by serological tests from patients waiting for kidney transplantation].

Authors:  Shao-Jie Fu; Yan-Lin Feng; Li-Xin Yu; Yun Miao; Min Luo; Yi-Bin Wang; Yi-Chen Li; Shu-Han Chen; Lu-Lu Xiao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-06-20

2.  DEL phenotype.

Authors:  Dong H Kwon; S G Sandler; Willy A Flegel
Journal:  Immunohematology       Date:  2017-09

3.  Proceed with care: the "uncommon" serologic weak D phenotypes.

Authors:  Willy Albert Flegel
Journal:  Blood Transfus       Date:  2021-07       Impact factor: 3.443

4.  Weak D Testing is not Required for D- Patients With C-E- Phenotype.

Authors:  Sooin Choi; Sejong Chun; Hwan Tae Lee; HongBi Yu; Ji Young Seo; Duck Cho
Journal:  Ann Lab Med       Date:  2018-11       Impact factor: 3.464

Review 5.  DEL in China: the D antigen among serologic RhD-negative individuals.

Authors:  Qinan Yin; Willy Albert Flegel
Journal:  J Transl Med       Date:  2021-10-20       Impact factor: 5.531

6.  Elimination of pretransfusion RhD typing at Mackay Memorial Hospital, Taiwan-30-year experience (1988-2017).

Authors:  Marie Lin
Journal:  Vox Sang       Date:  2020-09-20       Impact factor: 2.144

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.